Cargando…

Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study

BACKGROUND: Adverse reactions, especially nephrotoxicity, are great concerns of intravenous colistin treatment. The role of substitutive nebulized colistin in treating nosocomial pneumonia caused by carbapenem-resistant Gram-negative bacterial (CR-GNB) in critically ill patients remains unknown. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Jia-Yih, Huang, Jhong-Ru, Lee, Chang-Ching, Tseng, Yen-Han, Pan, Sheng-Wei, Chen, Yuh-Min, Yang, Kuang-Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825688/ https://www.ncbi.nlm.nih.gov/pubmed/36609725 http://dx.doi.org/10.1186/s13613-022-01088-4

Ejemplares similares

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
por: Wang, Sheng-Huei, et al.
Publicado: (2021)

Clinical effectiveness of tigecycline in combination therapy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective multi-centre observational study
por: Yang, Kuang-Yao, et al.
Publicado: (2023)

Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB
por: Wang, Jiale, et al.
Publicado: (2023)

Clinical Outcomes and Prolonged SARS-CoV-2 Viral Shedding in ICU Patients with Severe COVID-19 Infection and Nosocomial Bacterial Pneumonia: A Retrospective Cohort Study
por: Sun, Chuan-Yen, et al.
Publicado: (2022)

Comparison of clinical outcomes in critically ill COVID-19 patients on mechanical ventilation with nosocomial pneumonia between Alpha and Omicron variants
por: Sun, Chuan-Yen, et al.
Publicado: (2023)

Analysis of the effect of cytomegalovirus infection in clinical outcomes and prolonged duration of SARS-CoV-2 shedding in intensive care unit patients with COVID-19 pneumonia
por: Shen, Hsiao-Chin, et al.
Publicado: (2023)

Emergence of Nosocomial Pneumonia Caused by Colistin-Resistant Escherichia coli in Patients Admitted to Chest Intensive Care Unit
por: El-Mokhtar, Mohamed A., et al.
Publicado: (2021)

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
por: Zhu, Yinggang, et al.
Publicado: (2021)

Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial
por: Pourheidar, Elham, et al.
Publicado: (2019)

Effectiveness of treatment with nebulized colistin in patients with COPD
por: Bruguera-Avila, Nuria, et al.
Publicado: (2017)

Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
por: Demirdal, Tuna, et al.
Publicado: (2016)

Development and Assessment of a Novel Predictive Nomogram to Predict the Risk of Secondary CR-GNB Bloodstream Infections among CR-GNB Carriers in the Gastroenterology Department: A Retrospective Case–Control Study
por: Zhang, Hongchen, et al.
Publicado: (2023)

Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital
por: Karli, Arzu, et al.
Publicado: (2013)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Nosocomial pneumonia in medico-surgical intensive care unit.
por: Chung, K. I., et al.
Publicado: (1992)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Size Distribution of Colistin Delivery by Different Type Nebulizers and Concentrations During Mechanical Ventilation
por: Liu, Ching-Yi, et al.
Publicado: (2019)

The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study
por: Wang, Sheng-Huei, et al.
Publicado: (2023)

Randomized Control Study of Nebulized Colistin as an Adjunctive Therapy in Ventilator-Associated Pneumonia in Pediatric Postoperative Cardiac Surgical Population
por: Bharathi, K. S., et al.
Publicado: (2022)

Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study
por: Feng, Jia-Yih, et al.
Publicado: (2021)

2231. Safety of Nebulized Colistin as Adjunctive Treatment of Lower Respiratory Tract Infections
por: Nadeem, Komal, et al.
Publicado: (2019)

Intensive care unit mishap during nebulization
por: Jindal, Monika, et al.
Publicado: (2015)

Intensive Care Unit mishap during nebulization
por: Raut, Monish S., et al.
Publicado: (2015)

Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization
por: Akkerman-Nijland, A. M., et al.
Publicado: (2020)

Nosocomial pneumonia in the intensive care unit: how should treatment failure be predicted?
por: Ranzani, Otavio T., et al.
Publicado: (2014)

Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015)

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review
por: Karaiskos, Ilias, et al.
Publicado: (2023)

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Michalopoulos, Argyris, et al.
Publicado: (2005)

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Mubareka, Samira, et al.
Publicado: (2005)

Evidence for Involvement of GNB1L in Autism
por: Chen, Ying-Zhang, et al.
Publicado: (2012)

Nosocomial Infection in the Intensive Care Unit
por: Maki, Dennis G., et al.
Publicado: (2008)

Clinical experiment with the use of colistin for the treatment of multiresistant Acinetobacter baumanii nosocomial infection
por: Safi, L, et al.
Publicado: (2009)

Genetic diversity of colistin resistance Nosocomial Acinetobacter baumannii strains from Iran
por: Seyyedi, Maryam, et al.
Publicado: (2021)

Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2021)

Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India
por: Kumari, Namrata, et al.
Publicado: (2022)

Incidence, risk factors and mortality of nosocomial pneumonia in Intensive Care Units: A prospective study
por: Alp, Emine, et al.
Publicado: (2004)

Nosocomial pneumonia and bacteraemia in the Belgian intensive care units (ICU) network: epidemiology and risk factors
por: Hanique, G, et al.
Publicado: (1997)

Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study
por: Daubin, Cédric, et al.
Publicado: (2005)

Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae
por: Chang, Ya-Ting, et al.
Publicado: (2020)

Genomic characterization of colistin-resistant Klebsiella pneumoniae isolated from intensive care unit patients in Egypt
por: Attalla, Eriny T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qg0cjuhc19g7h8ctnvu4e6oj1p